Successful desensitization to brentuximab vedotin after anaphylaxis

Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):e73-5. doi: 10.1016/j.clml.2013.11.003. Epub 2013 Nov 15.

Authors

Amy E O'Connell¹, Joyce P Lee², Christina Yee³, Jennifer Kesselheim⁴, Anahita Dioun³

Affiliations

¹ Department of Allergy/Immunology, Boston Children's Hospital, Boston, MA. Electronic address: [email protected].
² Department of Pharmacy, Boston Children's Hospital, Boston, MA.
³ Department of Allergy/Immunology, Boston Children's Hospital, Boston, MA.
⁴ Dana-Farber/Boston Children's Center for Cancer and Blood Disorders, Boston, MA.

PMID: 24373790
DOI: 10.1016/j.clml.2013.11.003

No abstract available

Keywords: Anaphylaxis; Anaplastic large cell lymphoma; Brentuximab vedotin; Desensitization; Drug allergy.

Publication types

Case Reports

MeSH terms

Anaphylaxis / prevention & control*
Brentuximab Vedotin
Desensitization, Immunologic / methods*
Humans
Immunoconjugates / therapeutic use*
Lymphoma, Large-Cell, Anaplastic / therapy*
Male
Treatment Outcome
Young Adult

Substances

Immunoconjugates
Brentuximab Vedotin